Philadelphia, PA and London, UK (Scicasts) - Thomson Reuters and GenomeQuest have announced a new partnership to integrate Thomson Reuters patent sequence data in GENESEQ with the GenomeQuest IP discovery tools. The product combination, available in September, provides intellectual property professionals and scientists with online, interactive access to an up-to-date, comprehensive source of biological sequence information.
GENESEQ is a database from Thomson Reuters containing more than 29 million patented biological sequences, from over 150,000 unique patents across the global patent issuing authorities. Now, in addition to text file FTP access, GENESEQ can be accessed alongside GenomeQuest GQ-Pat, a complementary source of patented sequences, to offer an extensive repository for patent sequence information. This information, delivered through GenomeQuest’s secure internet subscription service, offers users the potential to quickly and accurately discover comprehensive biological sequence information incorporated in patents and make faster and more reliable business decisions.
“Patented biological sequence databases today are fragmented, duplicative, and time-consuming to search and analyze,” said Jon Brett-Harris, executive vice president, Life Sciences at Thomson Reuters. “We are delighted to be working with GenomeQuest to incorporate our renowned GENESEQ database with their IP discovery tools and GQ-Pat. This collaboration gives access to a comprehensive store of information through an intuitive interface designed with the biological patent sequence researcher in mind.”
Ron Ranauro, CEO of GenomeQuest, said, “Searching for unique information in this combined solution, scientists can benefit by identifying information not available in the public domain, linking genes and targets to disease and giving them access to an easy-to-use source of patent information that can quickly give them an indication of patent activity around their molecule of interest.”
